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Summary:
The PhysioFlow bioimpedance cardiography device provides key measures of central systolic and diastolic 
and peripheral vascular function. Many of these variables have not been assessed for intrarater reliability 
and agreement during rest, submaximal exercise and high-intensity interval exercise. Twenty healthy adults 
(age: 26±4 years) completed two identical trials beginning with five minutes of rest followed by two 5-minute 
submaximal cycling bouts at 50% and 70% of peak power output. Subjects then completed ten 30-second 
cycling intervals at 90% of peak power output interspersed with 60 s of passive recovery. Bioimpedance 
cardiography (PhysioFlow; Manatec Biomedical, France) monitored heart rate, stroke volume, cardiac output, 
stroke volume index, cardiac index, ventricular ejection time, contractility index, ejection fraction, left 
cardiac work index, end diastolic volume, early diastolic filling ratio, systemic vascular resistance and 
systemic vascular resistance index continuously throughout both trials. Intraclass correlation coefficients 
(ICC), standard errors of measurement and minimal detectable differences were calculated for all variables. 
Heart rate, stroke volume, cardiac output, left cardiac work index and end diastolic volume demonstrated a 
good level of reliability (ICC>.75) at rest, during submaximal exercise and high-intensity interval exercise. 
All other variables demonstrated inconsistent reliability across activity types and intensities. When using 
the PhysioFlow device, heart rate, stroke volume, cardiac output, left cardiac work index and end diastolic 
volume were deemed acceptable for use regardless of exercise type (continuous vs. interval) or intensity (low, 
moderate, or high). However, other variables measured by this device appear less reliable.
Key words: bioimpedance cardiography, exercise, reliability, high-intensity interval exercise, cardiac 
output, minimal detectable differences, central haemodynamics, peripheral haemodynamics
Introduction
The ability to continuously measure haemody-
namic responses to exercise is important when as-
sessing or monitoring individuals before, during 
and following acute and chronic exercise. For ex-
ample, cardiac output has been used to determine 
exercise tolerance and cardiac function during ex-
ercise (Crisafulli, Orru, Melis, Tocco, & Concu, 
2003; Fletcher, et al., 2001) as well as during clini-
cal responses to physiological and pharmacologi-
cal stimuli (Leitman, et al., 2006; Parry & McF-
etridge-Durdle, 2006; Richard, et al., 2001; Tah-
vanainen, Leskinen, Koskela, Ilveskoski, Nord-
hausen, et al., 2009). Several methods are available 
for measuring cardiac output (see reviews: Sang-
kum, et al., 2016; Thiele, Bartels, & Gan, 2015; 
Warburton, Haykowsky, Quinney, Humen, & Teo, 
1999a, 1999b) during exercise, with the most com-
mon methods, based on the Fick principle, being 
thermodilution and dye-dilution techniques. These 
techniques are both accurate and reliable (Chris-
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tie, et al., 1987; Thrush, Downs, & Smith, 1995); 
however, they are invasive and require experienced 
technicians. The use of Doppler echocardiography 
and rebreathing methods (Thiele, Bartels, & Gan, 
2015) to measure cardiac output, while non-inva-
sive, are themselves limited in use due to requiring 
an experienced technician and not providing beat-
to-beat measurements, respectively (Jakovljevic, et 
al., 2008; Oberman, et al., 1989). 
Bioimpedance cardiography provides non-inva-
sive, beat-to-beat measures of cardiac output with-
out the need for highly skilled technicians; how-
ever, the validity and reliability of these devices 
are equivocal (Saugel, Cecconi, Wagner, & Reu-
ter, 2015; Thiele, Bartels, & Gan, 2015). It is likely 
the reliance on the evaluation of baseline thoracic 
impedance (Z0) provides a degree of error in meas-
urement for most devices as Z0 depends on mul-
tiple factors (Bernstein, 1986; Jensen, Yakimets, 
& Teo, 1995; Kubicek, Karnegis, Patterson, Wit-
soe, & Mattson, 1966; Penney, 1986). The Phys-
ioFlow (Manatec Biomedical, France) provides 
an alternative as it does not rely on the evaluation 
of Z0 nor does it need to measure blood resistiv-
ity or the distance between electrodes, both which 
introduce additional measurement error (Jensen, 
Yakimets, & Teo, 1995; Warburton et al., 1999b). 
Previous studies have assessed the validity of Phys-
ioFlow to measure cardiac output during rest and 
exercise against the direct Fick (Bougault, et al., 
2005; Charloux, et al., 2000; Richard, et al., 2001), 
dye-dilution (Robach, et al., 2008) and rebreathing 
methods (Tordi, Mourot, Matusheski, & Hughson, 
2004). Specifically, when assessed against the gold 
standard (i.e., direct Fick), the PhysioFlow has been 
shown to provide accurate measures of cardiac out-
put during rest and exercise (correlation coefficient 
= 0.71-0.94, mean difference = 0.04-3.20 L·min-1) 
(Bougault, et al., 2005; Charloux, et al., 2000; Rich-
ard, et al., 2001). Additionally, studies have reported 
generally moderate to good reliability and agree-
ment between repeated measures of cardiac output 
during rest and exercise (Charloux, et al., 2000; 
Hsu, et al., 2006; Richard, et al., 2001; Schultz, 
Climie, Nikolic, Ahuja, & Sharman, 2012; Tordi, 
Mourot, Matusheski, & Hughson, 2004; Welsman, 
Bywater, Farr, Welford, & Armstrong, 2005). An-
other often overlooked measurement relevant to a 
device’s applicability is the minimal detectable dif-
ference (MDD). This measurement is defined as the 
smallest change detectable above the threshold of 
measurement error (Beaten, et al., 2001; Portney & 
Watkins, 2009) and provides an indication of the 
sensitivity of a device to detect meaningful chang-
es. Knowing the MDD of all PhysioFlow measure-
ments will provide important information regarding 
the ability of the PhysioFlow to detect differences 
between populations and changes over time. We are 
unaware of any study to date which has examined 
the reliability of the PhysioFlow during dynamic 
non-steady-state exercise (i.e., high-intensity inter-
val exercise) and this is important given this mode 
of training is increasingly being prescribed to both 
healthy and chronic disease populations (Gibala, 
Little, Macdonald, & Hawley, 2012). 
The majority of literature assessing the reliabil-
ity of bioimpedance cardiography has focused on 
the measurement of heart rate, stroke volume and 
cardiac output. However, several other haemody-
namic indices are provided, including variables re-
lating to central systolic function (Leitman, et al., 
2006; Miles, Gotshall, Quinones, Wulfeck, & Kre-
itzer, 1990; van der Meer, et al., 1996), central dias-
tolic function (Pickett & Buell, 1993) and periph-
eral vascular function (Leitman, et al., 2006). Evi-
dence related to the validity and reliability of many 
of these measures are lacking; however, the ability 
to assess and monitor central systolic and diastol-
ic function as well as peripheral vascular function 
using one device in a variety of exercise conditions 
would be cost- and time-efficient for researchers 
and clinicians. As such, the purpose of this study 
was to assess the intrarater reliability and agree-
ment as well as to calculate the MDD of all variables 
measured and calculated by the PhysioFlow at rest, 
during submaximal steady-state exercise and high-
intensity interval exercise in a healthy population. 
Methods
Subjects
Twenty healthy adults (15 males; age: 26±4 
years; body mass index: 23.7±3.0 kg·m2) volun-
teered to participate in this study. Data from one 
subject were excluded from analyses due to poor 
signal quality during the interval section of the sec-
ond trial, resulting in a total of 19 subjects includ-
ed in the analyses. Subjects were excluded from 
the study if they presented with a history of car-
diovascular or metabolic disorders. Subjects were 
required to attend the laboratory on three separate 
occasions during which they performed a graded 
exercise test and two experimental sessions. Each 
session was separated by seven days. Subjects were 
asked to avoid strenuous physical activity the day 
before and the day of testing, with all testing com-
pleted at a similar time of day. All risks and benefits 
of participating in the study were provided to the 
subjects and written informed consent was obtained 
prior to data collection. This study received ethical 
approval from the Murdoch University Human Re-
search Ethics Committee (2015/146) prior to com-
mencement of the study and conformed to the Code 
of Ethics of the World Medical Association (Dec-
laration of Helsinki). 
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Procedures
Subjects completed all trials on an electroni-
cally braked Velotron cycle ergometer (RacerMate; 
USA) that was individually set up for each subject 
and kept consistent throughout the study. During 
the first visit, subjects completed a graded exercise 
test starting at 70 W, and increased 35 W·min-1 for 
males and 20 W·min-1 for females, until volitional 
exhaustion. The volume of oxygen consumption and 
carbon dioxide production were measured at 1Hz 
and presented as 30-s mean values using a Parvo 
TrueOne metabolic analysis system (ParvoMed-
ics; USA). The highest 30 s mean value was used 
to determine maximal oxygen consumption. The 
maximum power output achieved during this test 
was used to prescribe the intensity of exercise in 
the remaining sessions. 
The second and third testing sessions were com-
pleted in an identical manner and in an environmen-
tal chamber controlled at 24°C and 50% relative 
humidity. Subjects arrived at the laboratory at least 
3 h postprandial and in a euhydrated state. Hydra-
tion status was assessed using a hand-held refrac-
tometer (RHCN-200ATC Clinical Refractometer, 
G-tech, China) prior to beginning each trial. Urine 
specific gravity between 1.005-1.020 was classified 
as euhydrated, whereas values greater than 1.020 
indicated dehydration (Kavouras, 2002). Subjects 
were informed that if they were not fasted or if pre-
sented as dehydrated, they were required to return 
on another day for testing, but this did not occur. 
Each session began with five minutes of passive rest 
on the cycle ergometer followed by two 5-minute 
submaximal cycling bouts at 50% (140±34 W) and 
70% (196±48 W) of the maximum power output 
achieved during the graded exercise test (286±66 
W). Following one minute of passive recovery, sub-
jects then completed ten 30-second cycling intervals 
at 90% peak power output (252±62 W) interspersed 
with 60 s of passive recovery. Our interval config-
uration is in line with previous research (Freyssin, 
et al., 2012) and was chosen to elicit a physiologi-
cal response high enough to be considered high-
intensity, but still allowing adequate rest between 
intervals to minimise the effect of fatigue. Power 
output throughout the trials was maintained using 
Velotron cycling ergometer software. 
The volume of oxygen consumed was measured 
at 1 Hz using the ParvoMedics metabolic analy-
sis system. Haemodynamic responses were meas-
ured beat-by-beat using bioimpedance cardiography 
(PhysioFlow PF-07; Manatec Biomedical, France). 
Blood pressure, obtained by manual sphygmoma-
nometry during the fourth minute of the rest pe-
riod and each submaximal cycling bout, were en-
tered into the software to update the systemic vas-
cular resistance (SVR), systemic vascular resistance 
index (SVRi) and left cardiac work index (LCWi). 
Blood pressure measures were not updated during 
the interval cycling section due to the lag time ev-
ident between entering a new blood pressure and 
the adjustments observed in SVR, SVRi and LCWi; 
instead, the values obtained during the 70% peak 
power steady-state exercise were used for the de-
termination of SVR, SVRi and LCWi during high-
intensity interval exercise. While this may influence 
the validity of the data, it should have minimal in-
fluence on the reliability. 
Impedance cardiograph measures
Continuous online haemodynamic monitoring 
was completed using the PhysioFlow PF-07, which 
uses changes in thoracic bioimpedance during car-
diac ejection to calculate stroke volume. Detailed 
methodology of the PhysioFlow device has been 
described previously (Charloux, et al., 2000; Hsu, 
et al., 2006; Lepretre, Koralsztein, & Billat, 2004; 
Tonelli, Alnuaimat, Li, Carrie, & Mubarak, 2011). 
Two sets of two electrodes (Ag/AgCl, Skintact FS-
50), one ‘transmitting’ and one ‘sensing’, were 
placed above the supraclavicular fossa on the left 
base of the neck and at the midpoint of the thoracic 
region of the spine. Another set of two electrodes 
were used to monitor a single electrocardiographic 
signal (ECG; V1/V6 position). A high frequency al-
ternating current (66 kHz) of low amperage (4.5 mA 
peak to peak) was applied through the thorax pro-
ducing an impedance waveform which was time-
corrected to the simultaneous ECG recording. Since 
Z0 evaluation is not required with the PhysioFlow 
device, electrode positioning is not crucial (Tan, 
Lai, & Hwang, 2006). Thorough skin preparation 
(i.e., shaving, abrasion and alcohol wiping) was 
completed to ensure effective conductivity between 
the electrode and the skin.
An initial stroke volume index (SVical; mL.m2) 
was calculated during the autocalibration phase 
based on 30 consecutive heart beats with the sub-
ject sitting in an upright position on the cycle er-
gometer. During autocalibration, the largest imped-
ance variation observed during systole (Zmax - Zmin) 
and the largest rate of variation of the impedance 
signal (contractility index; dZ/dtpeak) were retained. 
The determination of SVical also depends on the 
thoracic flow inversion time (TFIT), acquired from 
the first mathematical derivative of the impedance 
signal (dZ/dt), according to the following equation: 
SVical = k ∙ [(dZ/dtmax) / (Zmax - Zmin)] ∙ W(TFITcal), 
where k is an empirically adjusted constant and W 
is a propriety correction algorithm. During the data 
acquisition phase, stroke volume (SV; mL) was cal-
culated according to the equation: SV = SVical ∙ ((dZ/
dtmax) / (dZ/dtmax)cal ∙ TFITcal ∙ TFIT)1/3 ∙ BSA, where 
body surface area (BSA; m2) was calculated ac-
cording to the Haycock equation (BSA = 0.024265 
∙ height0.3964 ∙ weight0.5378) (Haycock, Schwartz, & 
Wisotsky, 1978). Cardiac output (L∙min-1) was cal-
culated using the following equation: CO = HR ∙ 
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SVi ∙ BSA, where heart rate (HR; bpm) was deter-
mined from the R-R interval on the first deriva-
tive of the ECG signal (dECG/t) as this provides a 
more stable signal. Cardiac index (CI; L∙min-1∙m2) 
was calculated as the ratio of CO to BSA. Ventric-
ular ejection time (VET; ms) was measured from 
the dZ/dt and was defined as the time between the 
opening (B point) and closing (X point) of the aor-
tic valve. Left ventricular ejection fraction (EF; %) 
was calculated according the Capan equation (van 
der Meer, et al., 1996): EF = 0.84 – (0.64 ∙ PEP) / 
VET, where PEP is the pre-ejection period, defined 
as the time between the onset of the Q wave of the 
ECG and the B point. LCWi (kg∙m-1∙m2) was calcu-
lated according to the following equation: LCWi = 
0.0144 ∙ CI ∙ (MAP - PAOP), where MAP (mmHg) 
is the mean arterial pressure calculated from the 
systolic and diastolic blood pressure entered by the 
user, and PAOP is the pulmonary artery occlusion 
pressure which was by default set as 10 mmHg dur-
ing the calibration procedure. End diastolic volume 
(EDV; mL) was calculated as the ratio of SV to EF. 
The early diastolic filling ratio (EDFR) was meas-
ured on the dZ/dt and was defined as the ratio of 
the O wave to the S wave. Systemic vascular resist-
ance (Dyn∙s-1∙cm5) was calculated by the following 
equation: SVR = 80 ∙ (MAP – CVP) / CO, where 
CVP is the central venous pressure, which was by 
default set as 7 mmHg during the calibration pro-
cedure. Systemic vascular resistance index (Dyn∙s-
1∙cm5∙m2) was calculated by the following equation: 
SVRi = 80 ∙ (MAP – CVP) / CI. 
Statistical analysis
Guidelines for reporting reliability and agree-
ment studies (Kottner, et al., 2011) suggest, for con-
tinuous variables, reliability should be assessed 
using intraclass correlation coefficients (ICC) and 
agreement using standard errors of measurement 
(SEM). Mean values for all variables (i.e., 19 paired 
measures) obtained during the final minute of the 
rest period and submaximal steady-state exercis-
es (50% and 70% of peak power), were analysed 
for intrarater reliability and agreement. During the 
high-intensity interval exercise, mean values calcu-
lated only for data collected during the 10 intervals 
and not the recovery period (i.e., 19 paired meas-
ures) were used for analyses. Estimates of reliabil-
ity (ICC with 95% confidence intervals) and agree-
ment (SEM) were calculated for all the PhysioFlow-
derived variables during all conditions. Variables 
with an ICC greater than 0.75 were considered in-
dicative of good reliability, while those below 0.75 
were considered poor to moderately reliable (Port-
ney & Watkins, 2009). MDD using 95% confidence 
intervals were calculated according to the follow-
ing equation: MDD = z ∙ SEM ∙ √2 (Beaten, et al., 
2001; Portney & Watkins, 2009), where z = 1.96 
for 95 % confidence intervals. Differences in urine 
specific gravity, oxygen consumption and all the 
PhysioFlow-derived variables between trials were 
determined using a dependent t-test. All data are 
presented as mean ± standard deviation, unless oth-
erwise noted. All statistical analyses were conduct-
ed using SPSS (Version 22, IBM®, USA) software, 
with significance set at p≤.05. 
Results 
No differences were observed between trial one 
and trial two for urine specific gravity (1.008±0.006 
vs. 1.007±0.005; p=.37). Similarly, no differenc-
es were observed for oxygen consumption at rest 
(0.31±0.06 vs. 0.31±0.08 L∙min-1; p=.92), during 
50% steady-state cycling (2.02±0.45 vs. 2.05±0.50 
L∙min-1; p=.33), 70% steady-state cycling (2.86±0.67 
vs. 2.88±0.70 L∙min-1; p=.56), or during high-in-
tensity interval cycling (1.87±0.46 vs. 1.82±0.46 
L∙min-1; p=.24).
The intrarater reliability and agreement of 
the PhysioFlow-derived variables for central sys-
tolic function (Table 1), central diastolic function 
(Table 2) and peripheral vascular function (Table 3)
at rest, during steady-state cycling and interval cy-
cling are presented. HR and LCWi were greater 
during the high-intensity interval exercise in trial 
one compared with trial two (p=.04 and p=.03, re-
spectively). Additionally, EDV was greater dur-
ing trial one compared with trial two during rest 
(p=.02), 50% steady-state (p=.03), 70% steady-state 
(p=.03) and during the high-intensity interval exer-
cise (p=.02). No other significant differences were 
observed for any other variables between trial one 
compared to trial two.
Discussion and conclusions
The main objective of this study was to deter-
mine the intrarater reliability and agreement of all 
the PhysioFlow-derived variables at rest, during 
submaximal steady-state exercise and high-inten-
sity interval exercise in a healthy population. Ad-
ditionally, we have calculated MDD for all the vari-
ables during each condition to provide researchers 
and clinicians with valuable information regarding 
the sensitivity of PhysioFlow to detect changes be-
tween repeated measures. The variables demon-
strating good reliability (ICC>0.75) across exercise 
conditions were HR, SV, CO, LCWi and EDV. All 
other central and peripheral haemodynamic varia-
bles demonstrated suboptimal reliability (ICC<0.75) 
during some or all of the rest and exercise condi-
tions. 
Central systolic function 
The ability to measure HR, SV and CO is im-
portant to determine cardiovascular health (Esposi-
to, Mathieu-Costello, Shabetai, Wagner, & Richard-
son, 2010) as well as monitor cardiovascular stress 
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Table 1. Intrarater reliability and agreement of central systolic function variables measured or calculated using PhysioFlow at 
rest, during steady-state cycling (50% and 70% peak power output) and interval cycling (90% peak power output) 
Trial 1
(mean±SD)
Trial 2
(mean±SD) Difference
ICC
(95% CI’s) SEM MDD
Resting HR
SV
CO
SVi
CI
VET
CTI
EF
LCWi
76±11
88±24
6.57±1.64
47.28±10.32
3.56±0.77
340±53
218±84
72.56±15.51
4.54±1.31
78±12
82±18
6.25±1.13
44.66±8.77
3.53±0.75
352±43
245±67
77.36±9.23
4.24±1.15
1.5±8.0
-5.4±17.2
-0.3±1.1
-2.6±9.1
0.0±0.8
12.2±53.6
27.7±77.6
4.8±15.4
-0.3±0.9
.86 (.63, .95)
.81 (.49, .93)
.81 (.52, .93)
.71 (.23, .89)
.60 (-.04, .85)
.56 (-.15, .83)
.65 (.10, .87)
.43 (-.47, .78)
.84 (.59, .94)
3.01
7.60
0.47
4.94
0.51
35.76
45.78
11.60
0.36
8.35
21.05
1.31
13.70
1.40
99.09
126.87
32.14
0.99
50% steady-
state
HR
SV
CO
SVi
CI
VET
CTI
EF
LCWi
142±15
113±27
15.78±3.31
61.00±11.06
8.56±1.38
242±26
376±127
81.20±10.67
12.73±3.24
142±16
109±23
15.29±2.87
59.06±10.06
8.71±2.51
240±29
386±104
84.93±6.75
11.88±2.40
0.3±7.1
-4.1±18.2
-0.5±2.3
-1.9±10.0
0.2±2.1
-2.7±27.9
9.7±126.3
3.7±11.1
-0.9±2.2
.94 (.85, .98)
.85 (.60, .94)
.85 (.60, .94)
.71 (.26, .89)
.62 (.00, .85)
.64 (.07, .86)
.58 (-.36, .84)
.38 (-.61, .76)
.82 (.53, .93)
1.70
7.14
0.91
5.35
1.30
16.72
81.56
8.75
0.94
4.70
19.79
2.51
14.82
3.61
46.33
226.04
24.24
2.59
70% steady-
state
HR
SV
CO
SVi
CI
VET
CTI
EF
LCWi
171±13
115±26
19.42±3.93
61.90±9.59
10.51±1.38
215±23
378±90
81.97±8.09
16.17±3.79
171±14
110±22
18.71±3.41
59.81±9.09
10.65±2.87
223±27
390±114
84.54±6.75
15.32±3.03
0.0±6.3
-4.4±13.5
-0.7±2.4
-2.1±7.1
0.1±2.5
7.9±34.2
11.6±71.7
2.6±8.7
-0.8±2.4
.94 (.84, .98)
.91 (.78, .97)
.88 (.70, .96)
.83 (.57, .94)
.56 (-.14, .83)
.17 (-1.15, .68)
.86 (.64, .95)
.48 (-.35, .80)
.86 (.64, .95)
1.54
3.96
0.82
2.90
1.66
31.16
26.64
6.27
0.89
4.28
10.97
2.28
8.04
4.60
86.35
73.82
17.37
2.48
Interval HR
SV
CO
SVi
CI
VET
CTI
EF
LCWi
152±14*
117±26
17.66±3.75
63.07±9.90
9.54±1.42
218±20
393±108
81.77±7.91
14.70±3.73*
148±14
112±21
16.47±2.99
60.45±8.93
9.30±2.30
221±22
377±101
83.81±6.32
13.40±2.67
-4.0±8.6
-4.6±16.3
-1.2±2.9
-2.6±8.2
-0.2±2.2
2.7±11.6
-15.6±65.6
2.0±8.0
-1.3±2.5
.89 (.86, .92)
.87 (.83, .90)
.79 (.72, .84)
.73 (.64, .80)
.52 (.36, .64)
.61 (.48, .71)
.75 (.67, .811)
.51 (.35, .63)
.82 (.76, .86)
2.83
5.90
1.34
3.48
1.53
7.23
32.87
5.59
1.06
7.83
16.35
3.72
9.64
4.25
20.03
91.08
15.50
2.94
Note. SD: standard deviation; CV: coefficient of variation; ICC: intraclass correlation coefficient; CI: confidence interval; SEM: standard 
error of measurement; MDD: minimal detectable difference; HR: heart rate (bpm); SV: stroke volume (mL); CO: cardiac output (L·min-
1); SVi: stroke volume index (mL·m2); CI: cardiac index (L·min-1·m2); VET: ventricular ejection time (ms); CTI: contractility index (AU); 
EF: ejection fraction (%); LCWi: left cardiac work index (kg·m-1·m2). *trial 1 greater than trial 2 (p≤.05)
Table 2. Intrarater reliability and agreement of central diastolic function variables measured or calculated using PhysioFlow at 
rest, during steady-state cycling (50% and 70% peak power output) and interval cycling (90% peak power output) 
Trial 1
(mean±SD)
Trial 2
(mean±SD) Difference
ICC
(95% CI’s) SEM MDD
Resting EDV
EDFR
123.98±32.40*
52.88±10.75
107.67±25.40
49.53±8.50
-16.3±26.3
-3.3±12.0
.74 (.34, .90)
.38 (-.62, .76)
13.31
9.49
36.88
26.29
50% steady-
state
EDV
EDFR
139.23±29.17*
58.39±10.26
129.29±30.25
58.48±7.43
-9.9±18.1
0.1±9.3
.90 (.73, .96)
.63 (.03, .86)
5.78
5.68
16.02
15.74
70% steady-
state 
EDV
EDFR
140.17±29.75*
62.12±14.10
131.80±30.19
59.04±12.23
-8.4±15.0
-3.1±18.4
.93 (.83, .97)
.05 (-1.46, .64)
3.88
17.92
10.76
49.65
Interval EDV
EDFR
143±30.14*
65.05±9.28
134±29.23
65.48±9.18
-8.9±15.5
0.4±7.4
.91 (.88, .93)
.58 (.44, .68)
4.62
4.81
12.82
13.32
Note. SD: standard deviation; CV: coefficient of variation; ICC: intraclass correlation coefficient; CI: confidence interval; SEM: standard 
error of measurement; MDD: minimal detectable difference; EDV: end diastolic volume (mL); EDFR: early diastolic filling ratio (%). 
*trial 1 greater than trial 2 (p≤.05)
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during exercise (Fletcher, et al., 2001). Our find-
ings indicate a good level of reliability (ICC>.75) 
for these variables, as assessed using the Physio-
Flow, at rest and during submaximal steady-state 
exercise (Table 1). The level of reliability reported 
in this study is consistent with the previous Physi-
oFlow research (Schultz, et al., 2012; Welsman, et 
al., 2005), which has demonstrated good reliabil-
ity for SV (ICC=.88) and CO (ICC=.86) measured 
at peak oxygen consumption during a graded ex-
ercise test (Welsman, et al., 2005), as well as good 
reliability for HR, SV and CO when measured at 
three submaximal steady-state exercise workloads 
(40 W, 60% HRmax and 70% HRmax) (Schultz, et 
al., 2012). The use of high-intensity interval exer-
cise is a common technique to increase health and 
fitness in young (Rakobowchuk, et al., 2008), aging 
(Knowles, Herbert, Easton, Sculthorpe, & Grace, 
2015) and chronic diseased populations (Wisloff, et 
al., 2007). Extending on previous works (Schultz, 
et al., 2012; Welsman, et al., 2005), we observed 
a good level of reliability for HR (ICC=.89), SV 
(ICC=.87) and CO (ICC=.79) during high-intensity 
interval exercise. The use of 30-second efforts in 
this study did not allow for a physiological steady-
state, suggesting that the PhysioFlow is capable of 
obtaining reliable measures of HR, SV and CO in 
both steady-state and dynamic exercise conditions. 
In addition to HR, SV and CO, the PhysioFlow 
provides additional central systolic variables, name-
ly CI, SVi, VET, CTI, EF and LCWi (Table 1). Inter-
estingly, only LCWi demonstrated good reliability 
across conditions. The use of LCWi as measured 
by bioimpedance cardiography has been shown to 
distinguish between levels of left ventricular dys-
function during a dobutamine stress test (Leitman, 
et al., 2006) and increases in LCWi are consistent 
with aerobic exercise training (Jakovljevic, et al., 
2010). These data demonstrate the clinical utility 
of measuring LCWi and, in context of our reliabil-
ity data, suggest this measure would be valuable in 
future research investigating the acute and chron-
ic responses of LCWi during exercise. In contrast, 
the measurement of EF by bioimpedance cardiog-
raphy is presented as a time- and cost-efficient al-
ternative to echocardiography in a clinical setting 
(Parrott, Burnham, Quale, & Lewis, 2004); how-
ever, our results indicate this measure is unreliable. 
Our findings are not consistent with previous work 
(Schultz, et al., 2012) in which a good level of reli-
ability (ICC=.92 to .97) was observed for the meas-
ure of EF using the PhysioFlow at three submaxi-
mal steady-state intensities. In the present study, 
measures of EF (Table 1) were greater than those 
reported by Schultz et al. (2012); thus, it is possible 
that the PhysioFlow can provide reliable measures 
of EF under a certain threshold (e.g., 61%) and be-
come less reliable at higher values possibly due to 
changes in sensitivity of determining VET and PEP 
at higher heart rates. Irrespective, previous studies 
have observed equivocal results regarding the va-
lidity of EF estimated by bioimpedance cardiogra-
phy devices (Miles, et al., 1990; van der Meer, et 
al., 1996). Taken together, these data warrant cau-
tion when considering using this measure.
It is important to note that while previous re-
search has compared CI, SVi, VET and CTI be-
tween conditions or individuals, the results of the 
present study provide further insight into the con-
fidence of these findings. For instance, Vella et al. 
(2011) observed 1.1 L∙min-1∙m2 higher CI (meas-
ured by PhysioFlow) in obese compared with non-
obese adults during steady-state cycle exercise at 
65% peak aerobic capacity suggesting excess body 
mass is associated with increased cardiac stress 
during moderate intensity exercise. However, the 
MDD of CI at 50-70% of peak power output with-
in the present study (3.61-4.60 L∙min-1∙m2; Table 1) 
indicates this may not be a meaningful difference. 
Further, Boutcher et al. (2003) demonstrated great-
er CI and SVi at rest and in response to exercise in 
trained men compared with untrained and seden-
tary men. VET has been inversely correlated with 
aortic pulse wave velocity and thus arterial stiff-
Table 3. Intrarater reliability and agreement of peripheral vascular function variables calculated using PhysioFlow at rest, during 
steady-state cycling (50% and 70% peak power output) and interval cycling
Trial 1
(mean±SD)
Trial 2
(mean±SD) Difference
ICC
(95% CI’s) SEM MDD
Resting SVR
SVRi
1182±295
2083±530
1137±142
2069±379
-45.5±262.6
-13.7±655.1
.53 (-.23, .82)
-.02 (-1.65, .61)
181
648
502
1795
50% steady-
state
SVR
SVRi
552±87
969±177
552±97
997±215
-0.1±78.0
27.4±218.6
.78 (.43, .92)
.56 (-.16, .83)
37
146
101
404
70% steady-
state
SVR
SVRi
460±62
810±139
470±81
852±180
10.0±67.6
42.0±198.2
.72 (.26, .89)
.39 (-.59, .77)
36
155
100
429
Interval SVR
SVRi
539±128
906±164
555±99
979±186
16.3±140.6
72.9±246.5
.40 (.19, .54)
.46 (.28, .60)
110
181
304
502
Note. SD: standard deviation; CV: coefficient of variation; ICC: intraclass correlation coefficient; CI: confidence interval; SEM: standard 
error of measurement; MDD: minimal detectable difference; SVR: systemic vascular resistance (Dyn·s-1·cm5); SVRi: systemic vascular 
resistance index (Dyn·s-1·cm5·m2).
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ness (Salvi, et al., 2013) and positively correlated 
with pressure gradients in aortic stenosis (Kadem, 
et al., 2002). The 134.6 lower resting CTI in obese 
compared with non-obese adults observed by Vella 
et al. (2012), is greater than the MDD reported in 
the current study (126.9), supporting the conclu-
sion that obese individuals do, indeed, have signif-
icantly lower cardiac contractility than non-obese 
individuals.
Central diastolic function
Resting and exercise EDV is greater in com-
petitive compared with non-competitive runners 
(Crawford, Petru, & Rabinowitz, 1985) as well as 
following exercise training interventions (Esfan-
diari, Sasson, & Goodman, 2014). Our data dem-
onstrate that the PhysioFlow can reliably estimate 
EDV at rest and during steady-state and interval 
exercise (Table 2) corroborating and expanding on 
data from Schultz et al. (2012). Nevertheless, cau-
tion should be exercised when using this device 
to estimate EDV within certain situations. For in-
stance, our data indicate the PhysioFlow is capable 
of detecting differences in resting EDV (43 mL) 
between competitive and non-competitive runners 
(Crawford, Petru, & Rabinowitz, 1985) as they are 
beyond the calculated MDD at rest (Table 2; 36.88 
mL); however, changes in submaximal EDV (12 
mL) reported after a short-term high-intensity inter-
val training program (Esfandiari, Sasson, & Good-
man, 2014) are likely too small (MDD = 16.02 mL) 
to be considered a true effect when using this de-
vice. Bioimpedance-derived EDFR is analogous 
with the Doppler echocardiography-derived E/A 
ratio, a measure of diastolic function dependent on 
preload (Pickett & Buell, 1993). Indeed, E/A ratio 
is inversely correlated with age, blood pressure and 
aerobic capacity (Missault, et al., 1993). Given di-
astolic function is multifactorial (Little & Downes, 
1990), it is unlikely this measure alone is of any 
clinical relevance; however, when combined with 
Doppler echocardiography, it may provide useful 
information regarding central diastolic function 
(Pickett & Buell, 1993).
Peripheral vascular function
Systemic vascular resistance and SVRi estimat-
ed by bioimpedance cardiography have been used 
to assess cardiovascular responses to various physi-
ological stimuli (Bogaard, et al., 1997; Freimark, et 
al., 2007; Ouzounian, Masaki, Abboud, & Green-
spoon, 1996; Tahvanainen, et al., 2011; Tahvanain-
en, Leskinen, Koskela, Ilveskoski, Alanko, et al., 
2009; Tahvanainen, Leskinen, Koskela, Ilveskoski, 
Nordhausen, et al., 2009). Although demonstrating 
the clinical utility of measuring SVR and SVRi, 
these studies did not use the PhysioFlow device. Our 
results demonstrate that SVRi is temporally unreli-
able at rest and during exercise, while SVR demon-
strated moderate to good reliability during steady-
state exercise and suboptimal reliability at rest and 
during high-intensity interval exercise (Table 3). 
Our results are comparable with those reported by 
Schultz et al. (2012) who demonstrated moderate 
to good reliability of SVR during steady-state ex-
ercise. Consequently, researchers and clinicians 
should acknowledge this limitation when consider-
ing the use of these variables. It should be noted that 
the participants in the current study were healthy 
and had normal BMI. It is possible that the findings 
outlined in this study are not representative of other 
populations, such as overweight and obese. Howev-
er, haemodynamic changes assessed by bioimped-
ance cardiography have previously been validated 
in obese individuals (Brown, et al., 2005; Richard, 
et al., 2001), patients with chronic obstructive pul-
monary disease and hyperinflation (Bougault, et al., 
2005), and pregnant populations (San-Frutos, et al., 
2011), suggesting bioimpedance cardiography can 
be used across various body habitus.
Our results indicate that HR, SV, CO, LCWi 
and EDV demonstrated a level of reliability accept-
able for use regardless of exercise type (continuous 
vs. interval) or intensity (low, moderate or high). 
Careful consideration should be given to the use 
of all other variables. Minimal detectable differ-
ences for all variables during rest and exercise were 
also provided to demonstrate the sensitivity of the 
PhysioFlow device. 
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